Lovro Lamot

Jul 18, 2023 | frontiersin.org | Lovro Lamot |Orsolya Horváth

Peng Zhaoyang1 Li Wei1 Jin Yanyan2 Xiang Wenqing1 Fu Haidong2* Mao Jianhua2* 1Department of Clinical Laboratory, Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China 2Department of Nephrology, Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China Objective: Previous studies have indicated a decrease in T regulatory cells (Tregs) among patients...

Jul 3, 2023 | frontiersin.org | Pratap Kumar |Kumar Ankur |Lovro Lamot |Xiaohui Li

Introduction Kawasaki disease (KD) is a medium-vessel vasculitis that predominantly affects young children (1, 2). The highest incidence of KD has been reported in Northeast Asian countries like Japan, South Korea, and Taiwan (3), ranging from 80 to 359 per 100,000 children below 5, and it continues to rise. Incidence data in the United States and Europe range from 15 to 20 per 100,000 children below 5. To date, no data on the nationwide incidence of KD has been gathered in India.

Jun 23, 2023 | frontiersin.org | Alexander Kay |Lovro Lamot |Takayuki Hoshina |Matthew Taylor

Introduction Throughout the course of the COVID-19 pandemic, hospitalization and mortality rates from SARS-CoV-2 infection have been markedly lower in children relative to adults. These differences in disease severity outcomes are multifactorial, but largely reflect age-related differences in immune responses against SARS-CoV-2 (1–5).